(Q33684972)

English

Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial (English)

1 reference

Europe PubMed Central

28 July 2017

phase II clinical trial

0 references

chemoradiotherapy

0 references

0 references

1 reference

based on heuristic

inferred from title

Andreas Unterberg

9

object named as

Andreas Unterberg

0 references

11

object named as

Jürgen Debus

1 reference

Europe PubMed Central

28 July 2017

10

object named as

Wolfgang Wick

1 reference

Europe PubMed Central

28 July 2017

Meinhard Kieser

2

object named as

Meinhard Kieser

1 reference

Europe PubMed Central

28 July 2017

Stephanie E. Combs

1

object named as

Stephanie E Combs

1 reference

Europe PubMed Central

28 July 2017

author name string

Stefan Rieken

3

1 reference

Europe PubMed Central

28 July 2017

Daniel Habermehl

4

1 reference

Europe PubMed Central

28 July 2017

Oliver Jäkel

5

1 reference

Europe PubMed Central

28 July 2017

Thomas Haberer

6

1 reference

Europe PubMed Central

28 July 2017

Anna Nikoghosyan

7

1 reference

Europe PubMed Central

28 July 2017

Renate Haselmann

8

1 reference

Europe PubMed Central

28 July 2017

language of work or name

0 references

publication date

6 September 2010

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

10

1 reference

Europe PubMed Central

28 July 2017

478

1 reference

Europe PubMed Central

28 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-10-478

0 references

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944178

28 July 2018

Carbon ion radiotherapy for pediatric patients and young adults treated for tumors of the skull base

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944178

28 July 2018

Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944178

28 July 2018

Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944178

28 July 2018

Carbon ion radiotherapy of skull base chondrosarcomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944178

28 July 2018

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944178

28 July 2018

Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944178

28 July 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944178

28 July 2018

Relative biological effectiveness (RBE) values for proton beam therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944178

28 July 2018

Tolerance of normal tissue to therapeutic irradiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944178

28 July 2018

A Multiple Testing Procedure for Clinical Trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944178

28 July 2018

An analysis of dose-effect relationship in the radiotherapy of malignant gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944178

28 July 2018

Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-478

21 January 2018

High linear energy transfer carbon radiation effectively kills cultured glioma cells with either mutant or wild-type p53.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-478

21 January 2018

Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-478

21 January 2018

Sample-size formula for the proportional-hazards regression model

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-478

21 January 2018

Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-478

21 January 2018

Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-478

21 January 2018

Particle radiation therapy using proton and heavier ion beams

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-478

21 January 2018

Cell cycle checkpoint and apoptosis induction in glioblastoma cells and fibroblasts irradiated with carbon beam

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-478

21 January 2018

Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944178

30 October 2018

Carbon ion radiation therapy for high-risk meningiomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20819220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-10-478

1 reference

Europe PubMed Central

28 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33684972&oldid=2018553725"